It’s springtime in a non-election year. A time to decompress from political commentary, prep for Fourth of July parties, and gear up for summer vacations. But a funny thing happened on the way to sun and fun, in one of the world’s most desirable vacation spots: San Diego County Supervisor Nora Vargas, re-elected by voters just last fall, unexpectedly resigned shortly thereafter....

The US House of Representatives passed the One Big Beautiful Bill Act by a single vote right before lawmakers left DC for Memorial Day weekend. As the bill continues to be dissected and scrutinized in the media, its advancement to the US Senate will no doubt cause another story to resurface....

A new federal enforcement deadline is set to reshape access to some of the country’s most in-demand weight-loss drugs. Starting May 22, the U.S. Food and Drug Administration (FDA) will prohibit most pharmacies and providers from producing or distributing compounded versions of GLP-1 medications semaglutide and tirzepatide, active ingredients in blockbuster drugs including Ozempic, Wegovy, Mounjaro, and Zepbound....